These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 35180382)

  • 1. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
    Polaris Observatory HCV Collaborators
    Lancet Gastroenterol Hepatol; 2022 May; 7(5):396-415. PubMed ID: 35180382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of hepatitis C virus in children in 2018: a modelling study.
    Schmelzer J; Dugan E; Blach S; Coleman S; Cai Z; DePaola M; Estes C; Gamkrelidze I; Jerabek K; Ma S; Montoya S; Razavi-Shearer D; Razavi-Shearer K; Robbins-Scott S; Razavi H; El Sayed MH
    Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):374-392. PubMed ID: 31954439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study.
    Dugan E; Blach S; Biondi M; Cai Z; DePaola M; Estes C; Feld J; Gamkrelidze I; Kottilil S; Ma S; Mathur P; Montoya S; Razavi-Shearer D; Razavi-Shearer K; Robbins-Scott S; Schmelzer J; Razavi H
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):169-184. PubMed ID: 33515496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.
    Polaris Observatory HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):161-176. PubMed ID: 28404132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global reporting of progress towards elimination of hepatitis B and hepatitis C.
    Cui F; Blach S; Manzengo Mingiedi C; Gonzalez MA; Sabry Alaama A; Mozalevskis A; Séguy N; Rewari BB; Chan PL; Le LV; Doherty M; Luhmann N; Easterbrook P; Dirac M; de Martel C; Nayagam S; Hallett TB; Vickerman P; Razavi H; Lesi O; Low-Beer D
    Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):332-342. PubMed ID: 36764320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs.
    Grebely J; Larney S; Peacock A; Colledge S; Leung J; Hickman M; Vickerman P; Blach S; Cunningham EB; Dumchev K; Lynskey M; Stone J; Trickey A; Razavi H; Mattick RP; Farrell M; Dore GJ; Degenhardt L
    Addiction; 2019 Jan; 114(1):150-166. PubMed ID: 30035835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
    Polaris Observatory Collaborators
    Lancet Gastroenterol Hepatol; 2023 Oct; 8(10):879-907. PubMed ID: 37517414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global epidemiology and genotype distribution of the hepatitis C virus infection.
    Gower E; Estes C; Blach S; Razavi-Shearer K; Razavi H
    J Hepatol; 2014 Nov; 61(1 Suppl):S45-57. PubMed ID: 25086286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
    Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany.
    Tergast TL; Blach S; Tacke F; Berg T; Cornberg M; Kautz A; Manns M; Razavi H; Sarrazin C; Serfert Y; van Thiel I; Zeuzem S; Wedemeyer H
    J Viral Hepat; 2022 Jul; 29(7):536-542. PubMed ID: 35357770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.
    Petruzziello A; Marigliano S; Loquercio G; Cozzolino A; Cacciapuoti C
    World J Gastroenterol; 2016 Sep; 22(34):7824-40. PubMed ID: 27678366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C prevalence and elimination planning in Pakistan, a bottom-up approach accounting for provincial variation.
    Mooneyhan E; Qureshi H; Mahmood H; Tariq M; Maqbool NA; Anwar M; Aslam M; Azam F; Blach S; Khan AG; Hamid S; Hussain T; Akhter MK; Khan A; Khan U; Khowaja S; Mahmood K; Mazhar S; Nawaz A; Rose A; Ghorezai GSA; Shah S; Sarwar SZ; Razavi H
    J Viral Hepat; 2023 Apr; 30(4):345-354. PubMed ID: 36650932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.
    Schorr O; Blach S; Thurnheer C; Ruis C; Dufour JF
    PLoS One; 2022; 17(8):e0272518. PubMed ID: 35960770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.
    Bruggmann P; Negro F; Bihl F; Blach S; Lavanchy D; Müllhaupt B; Razavi H; Semela D
    Swiss Med Wkly; 2015; 145():w14221. PubMed ID: 26715488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global timing of hepatitis C virus elimination in high-income countries.
    Razavi H; Sanchez Gonzalez Y; Yuen C; Cornberg M
    Liver Int; 2020 Mar; 40(3):522-529. PubMed ID: 31815353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.
    Rusch U; Robbins S; Razavi H; Vernazza P; Blach S; Bruggmann P; Müllhaupt B; Negro F; Semela D
    Swiss Med Wkly; 2019 Jan; 149():w14694. PubMed ID: 30673118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.
    Polaris Observatory Collaborators
    Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):383-403. PubMed ID: 29599078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.